Instrument NameHls Therapeutics IncInstrument Symbol(HLS-T)

Instrument ExchangeTSX

TORONTO , Nov. 7, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease, announces its financial results for the three and nine months ended September 30, 2024 . All amounts are in thousands of United States ("U.S.") dollars unless otherwise stated.

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric...

Will release its Q3 fiscal 2024 financial results on Thursday, November 7. The Company will hold a conference ...

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q3 fiscal 2024 financial results on Thursday, November 7,...

TORONTO , Oct. 24, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q3 fiscal 2024 financial results on Thursday, November 7, 2024 . The Company will hold a conference call that same day at 8:30 a.m. ET to discuss its results. The call will be hosted by Mr. Craig Millian , Chief Executive Officer, and Mr. John Hanna , Chief Financial Officer. Slides to accompany management's prepared remarks will be available to view via the webcast .

Announces that CEO Craig Millian, Chief Executive Officer, will present at H.C. Wainwright's 26th Annual ...

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric...

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric...

Announces that it has entered into a Product Listing Agreement with the province of Alberta, for the ...

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric...

Will release its Q2 fiscal 2024 financial results on Thursday, August 8. The Company will hold a conference ...

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q2 fiscal 2024 financial results on Thursday, August 8,...